SIRT3-SOD2-ROS pathway is involved in linalool-induced glioma cell apoptotic death

• Authors: Yanhao Cheng , Chao Dai , Jian Zhang
• Languages of publication: EN

Abstracts

EN

Glioma is the most prevalent type of adult primary brain tumor and chemotherapy of glioma was limited by drug-resistance. Linalool is an acyclic monoterpene alcohol possessing various pharmacological activities. The present study was conducted to evaluate the effect of linalool on glioma cell growth. The effect of linalool on cell viability in U87-MG cells was investigated and the results showed that linalool significantly reduced cell viability in a concentration- and time-dependent manner. In addition, exposure of the cells to linalool resulted in a concentration-dependent increase of TUNEL-stained cells, indicating the occurrence of apoptotic cell death. Linalool decreased mitochondrial oxygen consumption rate, increased the expression of Bax and Bak, reduced the expression of Bcl-2 and Bcl-xl, and increased the activities of caspase 3 and caspase 9, leading to increase of apoptosis. Linalool resulted in a concentration-dependent decrease of SOD activity but had no significant effect on mRNA and protein expression of SOD2. Moreover, linalool resulted in a significant increase of the expression of acetylated SOD2. The mRNA and protein expression of SIRT3 was significantly inhibited by linalool. Immunoblot analysis showed that there was an evident protein/protein interaction between SOD2 and SIRT3 under normal condition. Linalool treatment significantly decreased the interaction between SOD2 and SIRT3. Overexpression of SIRT3 significantly inhibited linalool-induced increase of mitochondrial ROS production and apoptotic cell death, and decrease of cell viability. In summary, the data demonstrated that linalool exhibited inhibitory effect on glioma cells through regulation of SIRT3-SOD2-ROS signaling.

Keywords

EN

linalool; glioma; apoptotic cell death; SIRT3; SOD2

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2017
• Volume: 64
• Issue: 2
• Pages: 343-350

Dates

published

2017

received

2016-10-05

revised

2016-12-25

accepted

2017-01-05

(unknown)

2017-06-02

Contributors

author

Yanhao Cheng

• Department of Functional Neurosurgery, The People's Hospital of Linyi, Linyi 276003, Shandong, China

author

Chao Dai

• Department of Functional Neurosurgery, The People's Hospital of Linyi, Linyi 276003, Shandong, China

author

Jian Zhang

• Department of Functional Neurosurgery, The People's Hospital of Linyi, Linyi 276003, Shandong, China

References

• Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326. doi: 10.1126/science.281.5381.1322.
• Adamson DC, Rasheed BA, McLendon RE, Bigner DD (2010) Central nervous system. Cancer Biomark 9: 193-210. doi: 10.3233/cbm-2011-0177.
• Bardon S, Picard K, Martel P (1998) Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutr Cancer 32: 1-7. doi: 10.1080/01635589809514708.
• Batista PA, Werner MF, Oliveira EC, Burgos L, Pereira P, Brum LF, Story GM, Santos AR (2010) The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. J Pain 11: 1222-1229. doi: 10.1016/j.jpain.2010.02.022.
• Berliocchi L, Russo R, Levato A, Fratto V, Bagetta G, Sakurada S, Sakurada T, Mercuri NB, Corasaniti MT (2009) (-)-Linalool attenuates allodynia in neuropathic pain induced by spinal nerve ligation in c57/bl6 mice. Int Rev Neurobiol 85: 221-235. doi: 10.1016/S0074-7742(09)85017-4.
• Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113: 1953-1968. doi: 10.1002/cncr.23741.
• Cerchiara T, Straface SV, Brunelli E, Tripepi S, Gallucci MC, Chidichimo G (2015) Antiproliferative effect of linalool on RPMI 7932 human melanoma cell line: ultrastructural studies. Nat Prod Commun 10: 547-549.
• Chang MY, Shen YL (2014) Linalool exhibits cytotoxic effects by activating antitumor immunity. Molecules 19: 6694-6706. doi: 10.3390/molecules19056694.
• Chang MY, Shieh DE, Chen CC, Yeh CS, Dong HP (2015) Linalool Induces Cell Cycle Arrest and Apoptosis in Leukemia Cells and Cervical Cancer Cells through CDKIs. Int J Mol Sci 16: 28169-28179. doi: 10.3390/ijms161226089.
• Chen X, Hopke PK, Carter WP (2011) Secondary organic aerosol from ozonolysis of biogenic volatile organic compounds: chamber studies of particle and reactive oxygen species formation. Environ Sci Technol 45: 276-282. doi: 10.1021/es102166c.
• Crowell PL (1999) Prevention and therapy of cancer by dietary monoterpenes. J Nutr 129: 775s-778s.
• Danial NN (2007) BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 13: 7254-7263. doi: 10.1158/1078-0432.ccr-07-1598.
• Ding Z, Liu Y, Yao L, Wang D, Zhang J, Cui G, Yang X, Huang X, Liu F, Shen A (2015) Spy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma's resistance to tumor necrosis factor (TNF-alpha)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD. Cell Cycle 14: 2149-2159. doi: 10.1080/15384101.2015.1041688.
• do Socorro SR, Mendonca-Filho RR, Bizzo HR, de Almeida Rodrigues I, Soares RM, Souto-Padron T, Alviano CS, Lopes AH (2003) Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 47: 1895-1901. doi: 10.1128/AAC.47.6.1895-1901.2003.
• Friedman HS, Kerby T, Calvert H (2000) Temozolomide and treatment of malignant glioma. Clin Cancer Res 6: 2585-2597.
• Fuller GN, Scheithauer BW (2007) The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol 17: 304-307. doi: 10.1111/j.1750-3639.2007.00084.x.
• Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205: 613-621. doi: 10.1016/j.cancergen.2012.10.009.
• Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J (2010) Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 16: 2443-2449. doi: 10.1158/1078-0432.CCR-09-3106.
• Gu Y, Ting Z, Qiu X, Zhang X, Gan X, Fang Y, Xu X, Xu R (2010) Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology 268: 19-24. doi: 10.1016/j.tox.2009.11.013.
• Gupta S, Kass GE, Szegezdi E, Joseph B (2009) The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med 13: 1004-1033. doi: 10.1111/j.1582-4934.2009.00697.x.
• Han HD, Cho YJ, Cho SK, Byeon Y, Jeon HN, Kim HS, Kim BG, Bae DS, Lopez-Berestein G, Sood AK, Shin BC, Park YM, Lee JW (2016) Linalool-incorporated nanoparticles as a novel anticancer agent for epithelial ovarian carcinoma. Mol Cancer Ther 15: 618-627. doi: 10.1158/1535-7163.MCT-15-0733-T.
• Hao JH, Yu M, Liu FT, Newland AC, Jia L (2004) Bcl-2 Inhibitors Sensitize Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Uncoupling of Mitochondrial Respiration in Human Leukemic CEM Cells. Cancer Res 64: 3607-3616. 10.1158/0008-5472.can-03-3648.
• Jana S, Patra K, Sarkar S, Jana J, Mukherjee G, Bhattacharjee S, Mandal DP (2014) Antitumorigenic potential of linalool is accompanied by modulation of oxidative stress: an in vivo study in sarcoma-180 solid tumor model. Nutr Cancer 66: 835-848. doi: 10.1080/01635581.2014.904906.
• Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331-342. doi: 10.1016/S0092-8674(02)01036-X.
• Letizia CS, Cocchiara J, Lalko J, Api AM (2003) Fragrance material review on linalool. Food Chem Toxicol 41: 943-964. doi: 10.1016/S0278-6915(03)00015-2.
• Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR, Thompson CB (2000) The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 6: 1389-1399. doi: 10.1016/S1097-2765(00)00136-2.
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109. doi: 10.1007/s00401-007-0243-4.
• Mimica-Dukic N, Bugarin D, Grbovic S, Mitic-Culafic D, Vukovic-Gacic B, Orcic D, Jovin E, Couladis M (2010) Essential oil of Myrtus communis L. as a potential antioxidant and antimutagenic agents. Molecules 15: 2759-2770. doi: 10.3390/molecules15042759.
• Nakazato Y (2008) The 4th Edition of WHO Classification of Tumours of the Central Nervous System published in 2007. No Shinkei Geka 36: 473-491. doi: 10.11477/mf.1436100746.
• Ohgaki H (2009) Epidemiology of brain tumors. Methods Mol Biol 472: 323-342. doi: 10.1007/978-1-60327-492-0_14.
• Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310: 1842-1850. doi: 10.1001/jama.2013.280319.
• Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol (Suppl 2): ii1-ii56. doi: 10.1093/neuonc/not151.
• Paik SY, Koh KH, Beak SM, Paek SH, Kim JA (2005) The essential oils from Zanthoxylum schinifolium pericarp induce apoptosis of HepG2 human hepatoma cells through increased production of reactive oxygen species. Biol Pharm Bull 28: 802-807. doi: 10.1248/bpb.28.802.
• Peana AT, D'Aquila PS, Chessa ML, Moretti MD, Serra G, Pippia P (2003) (-)-Linalool produces antinociception in two experimental models of pain. Eur J Pharmacol 460: 37-41. doi: 10.1016/S0014-2999(02)02856-X.
• Peana AT, D'Aquila PS, Panin F, Serra G, Pippia P, Moretti MD (2002) Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine 9: 721-726. doi: 10.1078/094471102321621322.
• Pi H, Xu S, Reiter RJ, Guo P, Zhang L, Li Y, Li M, Cao Z, Tian L, Xie J, Zhang R, He M, Lu Y, Liu C, Duan W, Yu Z, Zhou Z (2015) SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy 11: 1037-1051. doi: 10.1080/15548627.2015.1052208.
• Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12: 662-667. doi: 10.1016/j.cmet.2010.11.015.
• Russo R, Ciociaro A, Berliocchi L, Cassiano MG, Rombola L, Ragusa S, Bagetta G, Blandini F, Corasaniti MT (2013) Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells. Fitoterapia 89: 48-57. doi: 10.1016/j.fitote.2013.05.014.
• Salvesen GS (2002) Caspases and apoptosis. Essays Biochem 38: 9-19. doi: 10.1042/bse0380009.
• Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D, Green DR, Reed JC, Froelich CJ, Salvesen GS (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273: 27084-27090. doi: 10.1074/jbc.273.42.27084.
• Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466. doi: 10.1016/S1470-2045(09)70025-7.
• Tao NN, Zhou HZ, Tang H, Cai XF, Zhang WL, Ren JH, Zhou L, Chen X, Chen K, Li WY, Liu B, Yang QX, Cheng ST, Huang LX, Huang AL, Chen J (2016) Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway. Oncotarget 7: 50117-50130. doi: 10.18632/oncotarget.10319.
• Usta J, Kreydiyyeh S, Knio K, Barnabe P, Bou-Moughlabay Y, Dagher S (2009) Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels. Chem Biol Interact 180: 39-46. doi: 10.1016/j.cbi.2009.02.012.
• Vigneswaran K, Neill S, Hadjipanayis CG (2015) Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification. Ann Transl Med 3: 95. doi: 10.3978/j.issn.2305-5839.2015.03.57.
• Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma - are we there yet? Neuro Oncol 15: 4–27. doi: 10.1093/neuonc/nos273.
• Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59. doi: 10.1038/nrm2308.

Identifiers

DOI

10.18388/abp.2016_1438